The New York City Council voted Tuesday to approve the New York Blood Center’s rezoning proposal for its Upper East Side research facility, clearing the nonprofit’s last major hurdle to transform the 1930s-era building into a life sciences hub.
The 43-5 vote notably lacked the support of Councilman Ben Kallos, who represents the district containing the center—a rare instance of the legislative body bucking a longstanding tradition of voting in lockstep with the area’s council member on rezoning proposals.
The nonprofit is partnering with Longfellow, a Boston-based developer focused on the life sciences, on the project. Their current plan calls for a 13-story building that would stretch 233
→ Continue reading at Crain's New York Business
